Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 17;18(7):1345–1356. doi: 10.1002/alz.12484

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Biogen. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

The measurements of metabolites in AD, VaD, PDD, bvFTD, and DLB in Data set 3. Glycerophosphocholine (A), aspartic acid (B), hydroxypalmitic acid (C), choline (D), hexanoylcarnitine AcCa (6:0) (E), 4‐decenoylcarnitine AcCa (10:1) (F), tetradecadiencarnitine AcCa (14:2) (G), piperine (H), decanoylcarnitine AcCa (10:0) (I), L‐acetylcarnitine (J), and serotonin (K) levels were measured. Abbreviations: AD, Alzheimer's disease; VaD, vascular dementia; PDD, Parkinson disease dementia; bvFTD, behavioral variant frontotemporal dementia; DLB, dementia with Lewy body; FC, fold‐change. **P < .01, ***P < .001